Literature DB >> 22131192

Neuroradiological and neurofunctional examinations for patients with 22q11.2 deletion.

T Mori1, K Mori, E Fujii, Y Toda, M Miyazaki, M Harada, S Kagami.   

Abstract

Since the neuroradiological features of patients with 22q11.2 deletion syndrome are not well-understood, examinations using functional imaging were performed in this study. Brain magnetic resonance imaging (MRI) and 1H-magnetic resonance spectroscopy (MRS) were performed using a clinical 3-Tesla MR imager in 4 patients with 22q11.2 deletion syndrome (2 boys and 2 girls; aged 2-6 years.) and 20 age- and sex-matched healthy control subjects. Furthermore, interictal 123I-iomazenil (IMZ) single photon emission computed tomography (SPECT) was examined in 2 of the 4 patients. Among the 4 patients with 22q11.2 deletion syndrome, 2 patients showed polymicrogyria and 1 patient showed agyria. Those patients with brain malformations also showed abnormal brain artery patterns and decreased accumulation of IMZ in 123I-IMZ SPECT. Although all 4 patients showed epileptic discharges in their electroencephalograms (EEG), one patient with polymicrogyria had no seizure episodes. Decreases in γ-aminobutyric acid (GABA) corresponding to the areas of polymicrogyria and/or epileptic discharges in EEG were shown in all patients except for the patient with agyria. Although consistent evidence was not seen in patients with 22q11.2 deletion syndrome in this study, brain malformations and disturbances of the GABAergic nervous system would be underlying mechanisms of the neurodevelopmental abnormalities in this syndrome. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22131192     DOI: 10.1055/s-0031-1295479

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  6 in total

Review 1.  Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development.

Authors:  Daniel W Meechan; Thomas M Maynard; Eric S Tucker; Alejandra Fernandez; Beverly A Karpinski; Lawrence A Rothblat; Anthony-S LaMantia
Journal:  Prog Neurobiol       Date:  2015-04-09       Impact factor: 11.685

2.  Cxcr4 regulation of interneuron migration is disrupted in 22q11.2 deletion syndrome.

Authors:  Daniel W Meechan; Eric S Tucker; Thomas M Maynard; Anthony-Samuel LaMantia
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

3.  Glutamatergic markers, age, intellectual functioning and psychosis in 22q11 deletion syndrome.

Authors:  Laurens J M Evers; Therese A M J van Amelsvoort; Jaap A Bakker; Mariken de Koning; Marjan Drukker; Leopold M G Curfs
Journal:  Psychopharmacology (Berl)       Date:  2015-06-10       Impact factor: 4.530

4.  Constitutional chromosomal events at 22q11 and 15q26 in a child with a pilocytic astrocytoma of the spinal cord.

Authors:  Samantha Mascelli; Mariasavina Severino; Alessandro Raso; Paolo Nozza; Elisa Tassano; Giovanni Morana; Patrizia De Marco; Elisa Merello; Claudia Milanaccio; Marco Pavanello; Andrea Rossi; Armando Cama; Maria Luisa Garrè; Valeria Capra
Journal:  Mol Cytogenet       Date:  2014-05-15       Impact factor: 2.009

5.  22q11.2 Deletion Syndrome Is Associated With Impaired Auditory Steady-State Gamma Response.

Authors:  Kit Melissa Larsen; Giovanni Pellegrino; Michelle Rosgaard Birknow; Trine Nørgaard Kjær; William Frans Christiaan Baaré; Michael Didriksen; Line Olsen; Thomas Werge; Morten Mørup; Hartwig Roman Siebner
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

6.  Developmental excitatory-to-inhibitory GABA-polarity switch is disrupted in 22q11.2 deletion syndrome: a potential target for clinical therapeutics.

Authors:  Hayder Amin; Federica Marinaro; Davide De Pietri Tonelli; Luca Berdondini
Journal:  Sci Rep       Date:  2017-11-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.